Adjunctive Medications for Anxiety During Acute Alcohol Withdrawal

Primary Treatment Framework

The World Health Organization recommends benzodiazepines as front-line medication for alleviating withdrawal discomfort, including anxiety, in patients with alcohol withdrawal 1, 2

Diazepam (5-10 mg IV/IM every 6-8 hours) is the gold standard due to its long duration of action, providing smoother anxiety control and better seizure protection, as recommended by medical guidelines 3
Chlordiazepoxide (25-100 mg orally every 4-6 hours) is an effective alternative long-acting benzodiazepine, according to medical guidelines 3, 4
Lorazepam (1-4 mg every 4-8 hours) should be chosen for patients with liver failure, advanced age, respiratory failure, or obesity due to safer pharmacokinetics, as stated in medical guidelines 4

Haloperidol or other antipsychotics should only be used as adjuncts to benzodiazepines in severe withdrawal delirium that has not responded to adequate benzodiazepine doses, as recommended by the World Health Organization 1, 2
Antipsychotics must never be used as stand-alone medications for alcohol withdrawal anxiety, according to medical guidelines 1, 2

Thiamine (100-300 mg/day) must be administered to all patients with alcohol withdrawal before any dextrose-containing solutions, as recommended by medical guidelines 3, 4
Thiamine prevents Wernicke encephalopathy, not anxiety, but is mandatory in all cases, according to the World Health Organization 1, 2

Carbamazepine is an alternative to benzodiazepines for mild-to-moderate withdrawal, not an adjunct, as stated in medical guidelines 4
Anticonvulsants should not be used following an alcohol withdrawal seizure for prevention of further seizures, according to the World Health Organization 1, 2

Start with adequate benzodiazepines using CIWA-Ar guided dosing, as recommended by medical guidelines 3, 4
Limit benzodiazepine treatment to 10-14 days maximum to avoid dependence, according to medical guidelines 3, 4

Never use antipsychotics alone — they lower seizure threshold and worsen outcomes without benzodiazepines, as warned by the World Health Organization 1, 2
Dispense psychoactive medications in small quantities or supervise each dose to reduce misuse risk, as recommended by the World Health Organization 1, 2
Patients at risk of severe withdrawal should be managed inpatient where adjunctive medications can be safely titrated, according to the World Health Organization 1, 2